184 related articles for article (PubMed ID: 32101001)
1. Structural Effect on Adjuvanticity of Saponins.
Wang P; Ding X; Kim H; Michalek SM; Zhang P
J Med Chem; 2020 Mar; 63(6):3290-3297. PubMed ID: 32101001
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Evaluation of a QS-17/18-Based Vaccine Adjuvant.
Wang P; Škalamera Đ; Sui X; Zhang P; Michalek SM
J Med Chem; 2019 Feb; 62(3):1669-1676. PubMed ID: 30656932
[TBL] [Abstract][Full Text] [Related]
3. Vaccine Adjuvants Derivatized from
Wang P; Ding X; Kim H; Škalamera Đ; Michalek SM; Zhang P
J Med Chem; 2019 Nov; 62(21):9976-9982. PubMed ID: 31657920
[TBL] [Abstract][Full Text] [Related]
4. Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity.
Marciani DJ; Press JB; Reynolds RC; Pathak AK; Pathak V; Gundy LE; Farmer JT; Koratich MS; May RD
Vaccine; 2000 Jul; 18(27):3141-51. PubMed ID: 10856794
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Evaluation of QS-7-Based Vaccine Adjuvants.
Wang P; Škalamera Đ; Sui X; Zhang P; Michalek SM
ACS Infect Dis; 2019 Jun; 5(6):974-981. PubMed ID: 30920199
[TBL] [Abstract][Full Text] [Related]
6. Structure-Activity Relationship Study of
Kim H; Bai D; Ghosh S; Franks ML; Wang X; Yan C; Liu Z; Zhang P; Michalek SM; Leavenworth JW; Wang P
J Med Chem; 2022 Nov; 65(21):14589-14598. PubMed ID: 36318612
[TBL] [Abstract][Full Text] [Related]
7. Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100.
Marciani DJ; Reynolds RC; Pathak AK; Finley-Woodman K; May RD
Vaccine; 2003 Sep; 21(25-26):3961-71. PubMed ID: 12922132
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant activities of saponins from the root of Polygala senega L.
Katselis GS; Estrada A; Gorecki DK; Barl B
Can J Physiol Pharmacol; 2007 Nov; 85(11):1184-94. PubMed ID: 18066120
[TBL] [Abstract][Full Text] [Related]
9. Impact of C28 Oligosaccharide on Adjuvant Activity of QS-7 Analogues.
Škalamera Đ; Kim H; Zhang P; Michalek SM; Wang P
J Org Chem; 2020 Dec; 85(24):15837-15848. PubMed ID: 32463234
[TBL] [Abstract][Full Text] [Related]
10. Potentiating pneumococcal glycoconjugate vaccine PCV13 with saponin adjuvant VSA-1.
Kim H; Yu J; Bai D; Nahm MH; Wang P
Front Immunol; 2022; 13():1079047. PubMed ID: 36578488
[TBL] [Abstract][Full Text] [Related]
11. Elucidating the Mechanisms of Action of Saponin-Derived Adjuvants.
Marciani DJ
Trends Pharmacol Sci; 2018 Jun; 39(6):573-585. PubMed ID: 29655658
[TBL] [Abstract][Full Text] [Related]
12. Leaf saponins of Quillaja brasiliensis enhance long-term specific immune responses and promote dose-sparing effect in BVDV experimental vaccines.
Cibulski S; Rivera-Patron M; Suárez N; Pirez M; Rossi S; Yendo AC; de Costa F; Gosmann G; Fett-Neto A; Roehe PM; Silveira F
Vaccine; 2018 Jan; 36(1):55-65. PubMed ID: 29174676
[TBL] [Abstract][Full Text] [Related]
13. Starfish, Asterias amurensis and Asterina pectinifera, as potential sources of Th1 immunity-stimulating adjuvants.
Kawase O; Goo YK; Jujo H; Nishikawa Y; Xuan X
J Vet Med Sci; 2011 Feb; 73(2):227-9. PubMed ID: 20847539
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of the quillaja saponin semi-synthetic analog GPI-0100 in potentiating mucosal and systemic responses to recombinant HagB from Porphyromonas gingivalis.
Zhang P; Yang QB; Marciani DJ; Martin M; Clements JD; Michalek SM; Katz J
Vaccine; 2003 Oct; 21(27-30):4459-71. PubMed ID: 14505929
[TBL] [Abstract][Full Text] [Related]
15. Iscoms containing purified Quillaja saponins upregulate both Th1-like and Th2-like immune responses.
Sjölander A; van't Land B; Lövgren Bengtsson K
Cell Immunol; 1997 Apr; 177(1):69-76. PubMed ID: 9140097
[TBL] [Abstract][Full Text] [Related]
16. Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis.
Oliveira-Freitas E; Casas CP; Borja-Cabrera GP; Santos FN; Nico D; Souza LO; Tinoco LW; da Silva BP; Palatnik M; Parente JP; Palatnik-de-Sousa CB
Vaccine; 2006 May; 24(18):3909-20. PubMed ID: 16556475
[TBL] [Abstract][Full Text] [Related]
17. Development of Improved Vaccine Adjuvants Based on the Saponin Natural Product QS-21 through Chemical Synthesis.
Fernández-Tejada A; Tan DS; Gin DY
Acc Chem Res; 2016 Sep; 49(9):1741-56. PubMed ID: 27568877
[TBL] [Abstract][Full Text] [Related]
18. Effects of N-acylation on the immune adjuvanticity of analogs of the Quillaja saponins derivative GPI-0100.
Marciani DJ
Vaccine; 2022 Jul; 40(31):4169-4173. PubMed ID: 35688726
[TBL] [Abstract][Full Text] [Related]
19. Effect of saponin from Quillaja saponaria (molina) on antibody, tumour necrosis factor and interferon-gamma production.
Gebara VC; Petricevich VL; Raw I; da Silva WD
Biotechnol Appl Biochem; 1995 Aug; 22(1):31-7. PubMed ID: 7576254
[TBL] [Abstract][Full Text] [Related]
20. Novel ISCOMs from Quillaja brasiliensis saponins induce mucosal and systemic antibody production, T-cell responses and improved antigen uptake.
Cibulski SP; Mourglia-Ettlin G; Teixeira TF; Quirici L; Roehe PM; Ferreira F; Silveira F
Vaccine; 2016 Feb; 34(9):1162-71. PubMed ID: 26826546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
